Seizures in children treated for a primary brain tumor: risk factors, evaluation and management

2014 ◽  
Vol 9 (6) ◽  
pp. 627-637 ◽  
Author(s):  
Emily A Gertsch ◽  
Nicole J Ullrich
2020 ◽  
Vol 18 (1) ◽  
Author(s):  
Omid Reza Tamtaji ◽  
Mohammad Behnam ◽  
Mohammad Ali Pourattar ◽  
Michael R. Hamblin ◽  
Maryam Mahjoubin-Tehran ◽  
...  

AbstractGlioma is the most common primary brain tumor, and is a major health problem throughout the world. Today, researchers have discovered many risk factors that are associated with the initiation and progression of gliomas. Studies have shown that PIWI-interacting RNAs (piRNAs) and PIWI proteins are involved in tumorigenesis by epigenetic mechanisms. Hence, it seems that piRNAs and PIWI proteins may be potential prognostic, diagnostic or therapeutic biomarkers in the treatment of glioma. Previous studies have demonstrated a relationship between piRNAs and PIWI proteins and some of the molecular and cellular pathways in glioma. Here, we summarize recent evidence and evaluate the molecular mechanisms by which piRNAs and PIWI proteins are involved in glioma.


2021 ◽  
Vol 11 (9) ◽  
pp. 101-107
Author(s):  
Zygmunt Siedlecki ◽  
Małgorzata Szafrańska ◽  
Emilia Główczewska-Siedlecka ◽  
Maciej Śniegocki

Brain tumors cause widespread apprehension in society, associated with poor prognosis and death. Laymen most often associate them with glioblastoma multiforme which is in fact the most common malignant primary brain tumor (formerly it was considered the most common primary brain tumor, now it is thought that meningiomas are the most common). The interest of both the public and physicians is aroused by potential brain tumors risk factors. The only evidence based risk factor is ionizing radiation of head and neck. Other risk factors are also under consideration, however are not conclusive and different studies give different results. Given the widespread apprehension of brain tumors, knowledge of the risk factors seems obvious. In this manuscript, we have reviewed the current state of knowledge aboutf risk factors based on research. They confirm that apart from ionizing radiation, the existence of other risk factors is considered: cell phones, electromagnetic field, occupational exposure to raw meat, viruses. However, all these risk factors are not confirmed by reference results.


Cancer ◽  
2010 ◽  
pp. NA-NA ◽  
Author(s):  
Terri S. Armstrong ◽  
Stanley G. Cron ◽  
Elizabeth Vera Bolanos ◽  
Mark R. Gilbert ◽  
Duck-Hee Kang

1994 ◽  
Vol 22 (2) ◽  
pp. 143-150 ◽  
Author(s):  
Wan‐De Guo ◽  
Martha S. Linet ◽  
Wong‐Ho Chow ◽  
Jun‐Yao Li ◽  
William J. Blot

Neurosciences ◽  
2017 ◽  
Vol 22 (2) ◽  
pp. 107-113 ◽  
Author(s):  
Hasan Al-Dorzi ◽  
Abdullah Alruwaita ◽  
Bothaina Marae ◽  
Bushra Alraddadi ◽  
Hani Tamim ◽  
...  

Tumor Biology ◽  
2013 ◽  
Vol 34 (6) ◽  
pp. 3457-3464 ◽  
Author(s):  
Chen Xu ◽  
Lutao Yuan ◽  
Hengli Tian ◽  
Heli Cao ◽  
Shiwen Chen

Cells ◽  
2021 ◽  
Vol 10 (6) ◽  
pp. 1411
Author(s):  
Don Carlo Ramos Batara ◽  
Moon-Chang Choi ◽  
Hyeon-Uk Shin ◽  
Hyunggee Kim ◽  
Sung-Hak Kim

Glioblastoma multiforme (GBM) is the most common and aggressive type of primary brain tumor in adults, with a poor median survival of approximately 15 months after diagnosis. Despite several decades of intensive research on its cancer biology, treatment for GBM remains a challenge. Autophagy, a fundamental homeostatic mechanism, is responsible for degrading and recycling damaged or defective cellular components. It plays a paradoxical role in GBM by either promoting or suppressing tumor growth depending on the cellular context. A thorough understanding of autophagy’s pleiotropic roles is needed to develop potential therapeutic strategies for GBM. In this paper, we discussed molecular mechanisms and biphasic functions of autophagy in gliomagenesis. We also provided a summary of treatments for GBM, emphasizing the importance of autophagy as a promising molecular target for treating GBM.


2021 ◽  
Vol 22 (12) ◽  
pp. 6385
Author(s):  
Maya A. Dymova ◽  
Elena V. Kuligina ◽  
Vladimir A. Richter

Glioblastoma multiforme (GBM) is the most common and fatal primary brain tumor, is highly resistant to conventional radiation and chemotherapy, and is not amenable to effective surgical resection. The present review summarizes recent advances in our understanding of the molecular mechanisms of therapeutic resistance of GBM to already known drugs, the molecular characteristics of glioblastoma cells, and the barriers in the brain that underlie drug resistance. We also discuss the progress that has been made in the development of new targeted drugs for glioblastoma, as well as advances in drug delivery across the blood–brain barrier (BBB) and blood–brain tumor barrier (BBTB).


Sign in / Sign up

Export Citation Format

Share Document